The Photoluminescence, Drug Delivery and Imaging Properties of Multifunctional Eu3+/Gd3+ Dual-doped Hydroxyapatite Nanorods
Overview
Affiliations
The design and synthesis of multifunctional systems with high biocompatibility are very significant for the future of clinical applications. Herein, we report a microwave-assisted rapid synthesis of multifunctional Eu(3+)/Gd(3+) dual-doped hydroxyapatite (HAp) nanorods, and the photoluminescence (PL), drug delivery and in vivo imaging of as-prepared Eu(3+)/Gd(3+) doped HAp nanorods. The photoluminescent and magnetic multifunctions of HAp nanorods are realized by the dual-doping with Eu(3+) and Gd(3+). The PL intensity of doped HAp nanorods can be adjusted by varying Eu(3+) and Gd(3+) concentrations. The magnetization of doped HAp nanorods increases with the concentration of doped Gd(3+). The as-prepared Eu(3+)/Gd(3+)-doped HAp nanorods exhibit inappreciable toxicity to the cells in vitro. More importantly, the Eu(3+)/Gd(3+)-doped HAp nanorods show a high drug adsorption capacity and sustained drug release using ibuprofen as a model drug, and the drug release is governed by a diffusion process. Furthermore, the noninvasive visualization of nude mice with subcutaneous injection indicates that the Eu(3+)/Gd(3+)-doped HAp nanorods with the photoluminescent function are suitable for in vivo imaging. In vitro and in vivo imaging tests indicate that Eu(3+)/Gd(3+)-doped HAp nanorods have a potential in applications such as a multiple-model imaging agent for magnetic resonance (MR) imaging, photoluminescence imaging and computed tomography (CT) imaging. The Eu(3+)/Gd(3+) dual-doped HAp nanorods are promising for applications in the biomedical fields such as multifunctional drug delivery systems with imaging guidance.
Maleki-Ghaleh H, Kaminski B, Moradpur-Tari E, Raza S, Khanmohammadi M, Zbonikowski R Small. 2024; 20(52):e2405708.
PMID: 39449217 PMC: 11673459. DOI: 10.1002/smll.202405708.
Xie S, Guo M, Zeng D, Luo H, Zhong P, Deng Z Front Bioeng Biotechnol. 2024; 11:1310017.
PMID: 38268940 PMC: 10807042. DOI: 10.3389/fbioe.2023.1310017.
Jin Y, Sun L, Chen Y, Lu Y Cancer Med. 2024; 13(1):e6936.
PMID: 38197582 PMC: 10807586. DOI: 10.1002/cam4.6936.
Quaratesi I, Micu M, Rebba E, Carsote C, Proietti N, Di Tullio V Polymers (Basel). 2023; 15(24).
PMID: 38139929 PMC: 10747597. DOI: 10.3390/polym15244676.
Diez-Escudero A, Espanol M, Ginebra M Chem Sci. 2023; 15(1):55-76.
PMID: 38131070 PMC: 10732134. DOI: 10.1039/d3sc05344j.